Eam Investors, LLC Bluebird Bio, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$99.64 - $127.59 $1.15 Million - $1.48 Million	-11,587 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$105.8 - $150.94 $686,853 - $979,902	-6,492 Reduced 35.91%	11,587 $1.98 Million
Q4 2017 Feb 12, 2018	SELL	$81.25 - $130.7 $18,850 - $30,322	-232 Reduced 1.27%	18,079 $3.22 Million
Q3 2017 Nov 08, 2017	BUY	$57.74 - $91.42 $1.06 Million - $1.67 Million	18,311	18,311 $2.52 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.